BioSpace News Archive

Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to XPHOZAH® (tenapanor) for the treatment of pediatric hyperphosphatemia.

Today, the U.S. Food and Drug Administration granted marketing authorization to LetsGetChecked for the Simple 2 Test.

Guardant Health, Inc., a leading precision oncology company, announced that on November 8, 2023, the Compensation Committee of Guardant’s Board of Directors granted restricted stock units representing 50,741 shares of its common stock to 43 new non-executive employees under the Guardant Health, Inc.

Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and viral barrier indications, today announced its financial results for the three months ended September 30, 2023, and other recent developments.

BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.04 per common share, payable in Canadian Dollars on December 15, 2023, to shareholders of record at the close of business on November 30, 2023.

Madrigal Pharmaceuticals, Inc. announced that the company granted equity awards to 18 new employees with a grant date of November 13, 2023 as equity inducement awards under the terms of the company’s 2023 Inducement Plan.

Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) approved Augtyro™ (repotrectinib) for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC).

Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”) today announced that Steve Lisi, Chairman and Chief Executive Officer of Beyond Air, will participate in a fireside discussion and one-on-one meetings at the Piper Sandler Healthcare Conference being held November 28-30, 2023 in New York City.

Regeneron Pharmaceuticals, Inc. will webcast management participation.

Agilent Technologies Inc. announced the company has increased its quarterly dividend to 23.6 cents per share of common stock, a 5% increase over the previous dividend.